www.fdanews.com/articles/73726-global-pharmatech-receives-drug-approvals-for-the-singapore-market
GLOBAL PHARMATECH RECEIVES DRUG APPROVALS FOR THE SINGAPORE MARKET
June 27, 2005
Global Pharmatech, a company which combines R&D of botanical drug products, manufacturing, and sales and marketing for the over-the-counter (OTC) and prescription drug markets, announced that it's wholly owned subsidiary, Jilin Natural Pharmatech, has received approval from the Center for Drug Administration, Singapore Health Sciences Authority, for two new herbal drug products, Qing-Chang-Pai-Du and Qing-Xue capsules.